2 AI Stocks Trading at a Discount Right Now That I Think Wall Street Has Wrong

The article is bullish on Arlo and Evolv, highlighting Arlo's shift to AI-powered software and services, 28% annual recurring revenue growth, and analyst price targets around $22 versus a current price near $13.50. For Evolv, the key positive is customer retention: 92% of eligible K-12 customers stayed after its FTC settlement, while venue renewals and expansions continue across sports and entertainment. The piece is opinionated commentary rather than new company-reported results, so the likely direct market impact is limited.

Analysis

The market is still valuing both names off legacy product categories, but the more important shift is that each has become increasingly “install base + software attach” businesses. That matters because the valuation multiple should migrate from hardware replacement cycles toward subscription retention, upsell, and operating leverage; once that happens, marginal revenue becomes much stickier and less capital intensive. The second-order effect is competitive: incumbents selling commodity cameras or metal-detection hardware will have to defend against bundled AI workflows, not just spec-for-spec devices.

ARLO’s clearest setup is not consumer camera unit growth, but the possibility that its software layer becomes embeddable distribution for larger ecosystems. If that partner-led motion scales, the upside is less about household camera penetration and more about ARPU expansion and lower churn, which can re-rate the business over the next 6-12 months. The main risk is that the market overestimates how transferable the software is outside Arlo’s ecosystem; if partner deals remain narrow or take longer to monetize, the stock can stay range-bound despite improving fundamentals.

EVLV’s key signal is customer behavior after adverse headlines: retention following scrutiny suggests the product is operationally embedded, not merely “nice to have.” That implies renewals and expansions should continue even if new logo sales slow temporarily, which is important because the valuation debate hinges on lifetime value, not just bookings. The contrarian miss is that this could be a longer-duration story than the market expects — if institutions underwrite it as a tainted small-cap instead of a recurring-security platform, upside could persist for several quarters as the installed base compounds.

The biggest hidden risk across both names is execution credibility: one failed implementation, a partner pause, or another regulatory surprise could compress multiples quickly because these are still trust-sensitive businesses. But if the next 1-2 quarters confirm retention and expansion rather than flashy new wins, the re-rating can be abrupt because shorts are leaning on outdated business-model assumptions.

Key Decisions for Investors

• Long ARLO common on weakness over the next 2-6 weeks; target a re-rate toward $20-22 as the market digests software mix, with downside anchored if ARR growth stays in the high-20s and partner-led licensing expands.
• Use ARLO Jan-2026 call spreads to express upside with limited capital at risk; structure around a move from legacy-hardware multiple to software-peer valuation, since the main catalyst is multiple expansion rather than explosive top-line growth.
• Long EVLV common for a 3-9 month horizon; the thesis is renewal/expansion persistence, not new contract headlines. Risk/reward improves if the stock remains depressed despite continued K-12 retention and venue expansion.
• Pair trade: long EVLV / short a basket of traditional physical-security or access-control hardware names if available, to isolate the software-recurring revenue re-rating versus commodity hardware exposure.
• If ARLO or EVLV rally sharply on headline optimism without confirming quarterly retention metrics, take partial profits into strength; the main failure mode is valuation overshoot before operating proof catches up.